CatalystWireBeta

Form 8 - Advanced Medical Solutions Group plc

In brief · summary, not quotable

Evelyn Partners Group Limited has disclosed its interests in Advanced Medical Solutions Group plc as of April 17, 2026, holding 2,358,601 ordinary shares, representing 1.07% of the company's voting rights. The disclosure indicates no short positions, cash-settled or stock-settled derivatives, or rights to subscribe for new securities. There were no purchases or sales, or other dealings reported by Evelyn Partners Group Limited in relation to Advanced Medical Solutions Group plc's relevant securities on the specified date.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your AMS notes

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

KEY INFORMATION

(a) Full name of discloser:Evelyn Partners Group Limited
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure17/04/2026
  • In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A"
  • POSITIONS OF THE PERSON MAKING THE DISCLOSURE
Class of relevant security:Ordinary shares GBP0.05
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:2,358,6011.07%
(2) Cash-settled derivatives:N/A
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:N/A
TOTAL:2,358,6011.07%

All interests and all short positions should be disclosed

  • Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:N/A
Details, including nature of the rights concerned and relevant percentages:N/A

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

The currency of all prices and other monetary amounts should be stated.

Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit (£)
N/A
(b) Cash-settled derivative transactions
Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/A
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/A
(ii) Exercise
Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/A
(d) Other dealings (including subscribing for new securities)
Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

N/A

  • OTHER INFORMATION
  • Indemnity and other dealing arrangements

None

  • Agreements, arrangements or understandings relating to options or derivatives

None

Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:20/04/2026

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note